Back to User profile » Dr Karimi
Paper published by Dr Karimi:
Methodology
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Cost-utility analysis of immune tolerance induction therapy versus on-demand treatment with recombinant factor VII for hemophilia A with high titer inhibitors in Iran
Rasekh HR, Imani A, Karimi M, Golestani M
ClinicoEconomics and Outcomes Research 2011, 3:207-212
Published Date: 23 November 2011